BioCryst Pharmaceuticals | BCRX - Beban Bunga Utang





Beban Bunga Utang Perubahan Tanggal
Alnylam Pharmaceuticals USD -84.37M 166.42M 2026-09
BioCryst Pharmaceuticals USD 21.71M 7.58M 2026-06
Chugai Pharma JPY 95M 260M 2025-12
Daiichi Sankyo JPY 14.13B 10.56B 2026-09
DBV Technologies USD 461K 323.71K 2025-03
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Gilead Sciences USD 269M 22M 2026-09
GlaxoSmithKline GBP 219M 98M 2026-09
Glaxosmithkline GBP 264.74M 72.01M 2026-09
Incyte USD 605K 23K 2026-09
Ionis Pharmaceuticals USD 18M 1000K 2026-06
Karyopharm Therapeutics USD 12.55M 66K 2026-03
Neurocrine Biosciences USD 300K 2.6M 2026-09
Novavax USD 5.82M 342K 2025-12
PTC Therapeutics USD 3.21B 42.76M 2026-09
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
Ultragenyx Pharmaceutical USD 20M 2M 2026-09
Vertex Pharmaceuticals USD 36M 32.7M 2026-09